CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Daiichi Sankyo, Inc. v. Seagen Inc.

1:20-cv-01524

Overview

Case Number 1:20-cv-01524
Filing Date 2020-11-13
Status Terminated
Termination Date 2026-04-07
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 28:2201 Declaratory Judgment (Insurance)
Jury Demand Plaintiff

Parties

Defendant

Seagen Inc. Operating Company

Represented By

5 Attorneys Listed

Samantha G. Wilson

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-5018

Rodney Square, 1000 North King Street

Pieter S. de Ganon

UNDELIVERABLE EMAIL 2/1/2022

Michael A. Jacobs

Email: mjacobs@mofo.com

Bryan Wilson

Email: bwilson@mofo.com

Anne Shea Gaza

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6727

Rodney Square, 1000 North King Street

Plaintiff

AstraZeneca Pharmaceuticals, LP NPE (Individual / Inventor)

Represented By

6 Attorneys Listed

Thomas S. Fletcher

Email: tfletcher@wc.com

Jessica L. Pahl

Email: jpahl@wc.com

David I. Berl

Email: dberl@wc.com

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Daiichi Sankyo Company, Limited NPE (University / Research)

Represented By

7 Attorneys Listed

Preston K. Ratliff II

Email: prestonratliff@paulhastings.com

Joseph M. O'Malley

UNDELIVERABLE EMAIL 3/28/2022

Jeff A. Pade

Email: jeffpade@paulhastings.com

Isaac S. Ashkenazi

Email: isaacashkenazi@paulhastings.com

Ashley N. Mays-Williams

Email: ashleymayswilliams@paulhastings.com

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Steven J. Balick

Ashby & Geddes

Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Daiichi Sankyo, Inc. Operating Company

Represented By

7 Attorneys Listed

Preston K. Ratliff II

Email: prestonratliff@paulhastings.com

Joseph M. O'Malley

UNDELIVERABLE EMAIL 3/28/2022

Jeff A. Pade

Email: jeffpade@paulhastings.com

Isaac S. Ashkenazi

Email: isaacashkenazi@paulhastings.com

Ashley N. Mays-Williams

Email: ashleymayswilliams@paulhastings.com

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Steven J. Balick

Ashby & Geddes

Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 12 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 2 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (12): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (2 found):
PTAB: 2
USPTO PTAB Trial 2021-01-22
PGR2021-00042

Daiichi Sankyo, Inc. v. Seagen Inc.

Asserted Patent
Status: Terminated-Adverse Judgment
USPTO PTAB Trial 2020-12-23
PGR2021-00030

Daiichi Sankyo, Inc. et al. v. Seagen Inc.

Asserted Patent
Status: Final Written Decision
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US10808039
Monomethylvaline compounds capable of conjugation to ligands
Filed: 2019-07-10
Issued: 2020-10-20
Active (12.6 yrs remaining)
Expires: 2039-07-10

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

10

Dispositive

0

Granted

3

Denied

0

Pending / Review

6

Motions by Category

Procedural / Extension Motion 2 Motion to Stay 8

Key Dispositive Motions & Rulings

Motion to Stay Granted
ORDER re 10 MOTION to Stay or Dismiss filed by Seagen Inc. is GRANTED -- Case Stayed. Signed by Judge Leonard P. Stark on 4/28/21. (ntl) (Entered: 04/28/2021)
Entry #34 • 2021-04-28 Document →
Motion to Stay Granted
PROPOSED ORDER Granting Defendant SeaGen Inc.'s Motion to Stay or Dismiss by Seagen Inc.. (Attachments: # 1 Letter to the Hon. Leonard P. Stark from Anne Shea G...
Entry #33 • 2021-04-27 Document →
Motion to Stay Pending / Under Review
REQUEST for Oral Argument by AstraZeneca Pharmaceuticals LP re 10 MOTION to Stay or Dismiss - Defendant Seagen Inc.'s Motion to Stay or Dismiss. (Joyce, Alexand...
Entry #25 • 2021-02-08 Document →
Motion to Stay Pending / Under Review
[SEALED] REPLY BRIEF re 10 MOTION to Stay or Dismiss - Defendant Seagen Inc.'s Motion to Stay or Dismiss filed by Seagen Inc.. (Gaza, Anne) (Entered: 02/01/2021...
Entry #23 • 2021-02-01 Document →
Motion to Stay Pending / Under Review
[SEALED] ANSWERING BRIEF in Opposition re 10 MOTION to Stay or Dismiss - Defendant Seagen Inc.'s Motion to Stay or Dismiss filed by AstraZeneca Pharmaceuticals ...
Entry #17 • 2021-01-18 Document →
Motion to Stay Granted
MOTION to Stay or Dismiss - Defendant Seagen Inc.'s Motion to Stay or Dismiss - filed by Seagen Inc.. (Attachments: # 1 District of Delaware Local Rule 7.1.1. C...
Entry #10 • 2020-12-18 Document →

Docket Entries

(88 total)
Pleading / Complaint

COMPLAINT FOR DECLARATORY JUDGMENT OF NON-INFRINGEMENT filed with Jury Demand against Seagen Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3330059.) - filed by Daiichi Sankyo, Inc., Daiichi Sankyo Company, Limited, AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(myr) (Entered: 11/13/2020)

Entry #1 • 2020-11-13
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) (Entered: 11/13/2020)

Entry #2 • 2020-11-13
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,808,039. (myr) (Entered: 11/13/2020)

Entry #3 • 2020-11-13
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Daiichi Sankyo U.S. Holdings, Inc., Corporate Parent Daiichi Sankyo Company, Limited. for Daiichi Sankyo, Inc. filed by Daiichi Sankyo, Inc.. (myr) (Entered: 11/13/2020)

Entry #4 • 2020-11-13
1

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Daiichi Sankyo Company, Limited. (myr) (Entered: 11/13/2020)

Entry #5 • 2020-11-13
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc